Furthermore, the molecular details of ETAR structure and function uncovered here provide a basis for rational drug design aimed at manipulating endothelin receptor activity relevant to more frequent diseases, such as pulmonary hypertension. The gene discussed is EDNRA; the disease is pulmonary hypertension.